A team of specialized physicians and study experts consult our customers with all questions around respiratory medicine. Clinical and laboratory research activities focus on the development of new drugs and designing clinical trials phase I-IV involved in chronic lung disease (e.g., asthma, allergy, cystic fibrosis, immunodeficiency, COPD, infectious diseases and vaccine development).

We have established innovative tools to perform “proof of concept studies” to gain deeper insights into the complex mechanisms of the inflammatory processes for drug development. In this regard, our major topic is to test new drugs and compounds (e.g., monoclonal antibodies, functional food, probiotics) in prevention and treatment of chronic lung diseases.

Karin Zielen

CEO

Marina Semren

Study Nurse

Lale Kayan

Study Nurse

Prof. Dr. Stefan Zielen

Investigator

Dr. Dr. Richard Linde

Investigator

Lukas Zielen

General Management